secwatch.observer — SEC 8-K summary
======================================

Issuer:     Profusa, Inc. (PFSA)
CIK:        0001859807
Form:       8-K
Filed at:   2026-07-31T20:56:20+00:00
Accession:  0001213900-26-084064
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 5.03, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Profusa signs option to acquire G3 Vision Labs; G3 had ~$111M 2025 revenue
--------------------------------------------------------------------------

- Option to acquire G3 Vision Labs and its subsidiaries (Med Screen, Dominion, Acutis) for equity consideration.
- G3's unaudited 2025 net revenues ~$111M; combined entity would be a public diagnostics company.
- Conditions: Profusa must raise at least $30M in financing, obtain stockholder approval, refinance G3 debt.
- As option consideration, Profusa issued 201,120 common shares and 52,904 Series A Preferred shares (convertible to common 1:1000).
- Company believes it now meets Nasdaq minimum stockholders' equity of $2.5M for continued listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859807/000121390026084064/0001213900-26-084064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859807/000121390026084064/ea0300017-8k_profusa.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-084064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer